Clinical Trial

Low-dose Colchicine for CABG Graft Failure Prevention

Name: Low-dose Colchicine for CABG Graft Failure Prevention — clinical trial record (NCT07569328)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to evaluate whether daily low-dose colchicine (0.5 mg), administered in addition to the standard secondary prevention regimen recommended in clinical guidelines after coronary artery bypass grafting (CABG), can further prevent graft failure after CABG through a prospective, randomized, double-blind, placebo-controlled clinical trial.

Trial Details

NCT Number	NCT07569328
Lead Sponsor	Beijing Anzhen Hospital
Conditions	CAD - Coronary Artery Disease, CABG, Colchicine
Enrollment	622 participants
Start Date	2026-09-01
Primary Completion	2028-09-01 (estimated)
Study Completion	2029-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-06